If Australians won’t take the AstraZeneca vaccine, we must donate it to save lives elsewhere, especially while we queue-jump for more Pfizer doses.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai CSL
Menampilkan semua artikel
The government should be explicit about what proportion of the population will need to be vaccinated to warrant border reopening. Australians could then measure progress towards that goal.
If the vaccine had been widely rolled out, people would think they had HIV when they didn’t. But it’s not the end of this type of technology.
So-called mRNA vaccines are among the frontrunners in the global race to design a COVID vaccine. But as a new technology, most nations, including Australia, lack the capacity to produce them at scale.
The Australian government is working with two major pharmaceutical companies to facilitate the local production and supply of two different COVID-19 vaccines – if they’re proven to be effective.
Facts about Flu - We often hear of an expected pandemic and had a scare in 2009 with the swine flu, but how well are we prepared? Although no longer considered an immediate risk, the recent outbreak of…
A paper published in the Medical Journal of Australia today provides a possible reason for CSL’s 2010 flu vaccine causing febrile convulsions in children. The authors hypothesise that suboptimal use of…
The US Food and Drug Administration (FDA), has just issued a warning letter about the safety of CSL’s influenza vaccine, Fluvax. The letter follows FDA’s latest annual inspection of CSL laboratories and…
Kontributor teratas
-
Chief Executive, National Health and Medical Research Council
-
Hon Prof, Dept of Child & Adolescent Health, University of Sydney
-
Professor (Adjunct) in Infectious Diseases Epidemiology, Australian National University
-
Professor of Human Rights Law, Griffith University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Infectious Diseases Physician, St Vincent's Hospital, Sydney; Scientia Professor, Kirby Institute, UNSW Sydney
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
